June 13 (Reuters) - Future Pak said on Thursday it has
submitted a final attempt to acquire Vanda Pharmaceuticals ( VNDA )
and raised the cash portion of its offer.
Vanda previously rejected a proposal from Future Pak, saying
its offer significantly undervalued the company and was not in
the best interest of the firm and its shareholders.